Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 2, 2007, Pages 172-174

  Macy, Eric ^a   Bernstein, Jonathan A ^b   Castells, Mariana C ^c   Gawchik, Sandra M ^d   Lee, Tak H ^e   Settipane, Russell A ^f   Simon, Ronald A ^g   Wald, Jeffrey ^h   Woessner, Katharine M ^g   Sweetman, Lauri ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CROZER CHESTER MEDICAL CENTER   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f Scripps Clinic ^*

^g SCRIPPS CLINIC   (United States)

^h Kansas City Allergy and Asthma Associates   (Chile)

ⁱ American Academy of Allergy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; LEUKOTRIENE; SALBUTAMOL; STEROID;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; DESENSITIZATION; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG TOLERANCE; EYE DISEASE; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; HYPOTENSION; LARYNX DISORDER; LARYNX EDEMA; LUNG DISEASE; MAINTENANCE DRUG DOSE; NOSE DISEASE; OUTPATIENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROVOCATION TEST; REPEATED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; RHINOSINUSITIS; URTICARIA;

EID: 33846820329     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60692-8     Document Type: Article

References (11)

1. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180-186.
2. Fahrenholz JM. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol. 2003;24:113-124.
3. Mardiney M, Borish L. Aspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triad. Arch Otolaryngol Head Neck Surg. 2001;127:1287.
4. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J. 2000;16:432-436.
5. Gollapudi RR, Stevenson DD, Simon RA, Teirstein PS. Aspirin sensitivity. Implications for patients with coronary artery disease. JAMA. 2004;292:3017-3023.
6. Morwood K, Gills D, Smith W, Kette F. Aspirin-sensitive asthma. Intern Med J. 2005;35:240-246.
7. Cormican LJ, Farooque S, Altmann DR, Lee TH. Improvements in oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy. 2005;35:717-722.
8. American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:S483-S523.
9. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol. 1982;69:11-19.
10. Zeiss CR, Lockey RF. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol. 1976;57:440-448.
11. Lee JA, Simon RS, Stevenson DD. Selection of aspirin doses for aspirin desensitization in patients with aspirin exacerbated respiratory track disease. J Allergy Clin Immunol. In press.